Study Evaluating Efficacy News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Study Evaluating Efficacy. Real-time updates on events, politics, business and more.

Positive Data Demonstrates Gepotidacin is Non-Inferior to Alternative Treatment in GC

April 19, 2024

In a trial that compared gepotidacin to ceftriaxone plus azithromycin in patients with urogenital gonorrhea, gepotidacin presented a 92.6% microbiological success rate.

Comunidad Autonoma De Cataluna Chris Corsico European Society Of Clinical Microbiology European Congress Study Evaluating Efficacy Uncomplicated Urogenital

Source: pharmacytimes.com

Gepotidacin Demonstrates Non-Inferiority Treating Uncomplicated Urogenital Gonorrhea in Phase 3 Trial

February 27, 2024

Gepotidacin was compared with the combination of ceftriaxone and azithromycin in adolescent and adult patients with uncomplicated urogenital gonorrhea.

Chris Corsico Antibacterial Gepotidacin Evaluated Open Label Study Adult Participants Comparing Ceftriaxone Plus Azithromycin Uncomplicated Urogenital Gonorrhea Caused

Source: pharmacytimes.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Study Evaluating Efficacy News Today

Positive Data Demonstrates Gepotidacin is Non-Inferior to Alternative Treatment in GC

Gepotidacin Demonstrates Non-Inferiority Treating Uncomplicated Urogenital Gonorrhea in Phase 3 Trial

Explore More Categories